- Filed
- Feb 13, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 13, 2024 | 6.09M sh |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $16.6M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $13.6M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $13.41M |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $15.88M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $70.28M |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $45.38M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $54.39M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $57.01M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $155.73M |
| Total Assets | Q2 2024 · Dec 30, 2023 | $155.73M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $134.15M |
| Operating Income | Q2 2024 · Dec 30, 2023 | −$3.51M |
| Operating Income | Q2 2024 · Dec 30, 2023 | −$4.06M |
| Operating Income | Q2 2024 · Dec 31, 2022 | $2.49M |
| Operating Income | Q2 2024 · Dec 31, 2022 | $4.03M |
| Operating Income | Q2 2024 · Dec 30, 2022 | $2.49M |
| Operating Income | Q2 2024 · Dec 30, 2022 | $4.03M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 5.87M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 5.91M sh |
| Stock Repurchased | Q2 2024 · Dec 31, 2022 | $1.06M |
| Capex | Q2 2024 · Dec 31, 2022 | $11.64M |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | $3.74M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $89.53M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | $89.86M |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | $88.52M |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.31 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.49 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.31 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.49 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $3.73M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $7.56M |
| Net Income | Q2 2024 · Dec 31, 2022 | $1.81M |
| Net Income | Q2 2024 · Dec 31, 2022 | $2.87M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $6.21M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $11.59M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $36.08M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $73.84M |